Provinces must act to prevent another OxyContin debacle

Two solutions to increase pharmaceutical manufacturers’ accountability to Canadians and their governments

Provinces must act to prevent another OxyContin debacleBy Vanessa Gruben and Louise Bélanger-Hardy University of Ottawa The 10 provincial governments recently accepted a class-action settlement with Purdue Pharma, the maker of OxyContin. The settlement concerns the misleading claims Purdue Pharma allegedly made to physicians about the addictive nature of the drug. These claims may have contributed to Canada’s epidemic of opioid addiction.…

Canada’s refugee health-care program still falls short

Clinics, pharmacies and specialists continue to deny services to refugees and refugee claimants, based on the assumption they’re not covered by IFHP

Canada’s refugee health-care program still falls shortBy Y.Y. Brandon Chen and Vanessa Gruben University of Ottawa Despite changes to Canada’s refugee health-care program in April 2016, many people still don’t have adequate access to care, according to a series of interviews we conducted recently with refugee service providers in Ottawa. Health care for refugees in Canada is the responsibility of the Interim Federal…